Pharming Group (CHIX:PHARMa)
€ 0.7515 -0.2955 (-28.22%) Market Cap: 500.37 Mil Enterprise Value: 467.99 Mil PE Ratio: 0 PB Ratio: 2.64 GF Score: 81/100

Pharming Group NV Corporate Analyst Meeting Transcript

Mar 27, 2023 / 12:00PM GMT
Release Date Price: €1.14 (+13.52%)
Operator

Hello, everyone, and welcome to the Pharming conference call. My name is Nadia, and I will be coordinating the call today. (Operator Instructions) I will now hand over to your host, Dr. Sijmen De Vries, CEO, to begin. Please go ahead.

Sijmen de Vries
Pharming Group N.V. - President, CEO & Executive Director

Thank you very much, and good morning, good afternoon, ladies and gentlemen. On the occasion of the approval of leniolisib, now known under the brand name Joenja. And we're very proud to have achieved this FDA approval, obviously.

Before I go there, I would like to point out to the next slide, about forward-looking statements. As this presentation may contain forward-looking statements, and forward-looking statements are statements of further future expectations that are based upon management's current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements.

And of course, I'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot